Pressroom: Media Coverage

Showing 561 - 580 of 727 news items


Fake Cancer Drug Found in US

Gastrointestinal Oncology Acting Chief Leonard Saltz spoke about a counterfeit version of Avastin found in the United States. Counterfeiting has historically been more of a problem outside the US, and experts say counterfeits are a relatively small but still serious problem for the nation’s drug supply. Avastin is a commonly used drug for patients with colon, lung, and other cancers.

February 15, 2012
Rare Mutations Tied to Breast, Pancreatic Cancers

The inherited genetic mutations that can lead to Lynch syndrome may put people at extra risk for breast and pancreatic cancer, in addition to their well-known ties to colon and endometrial cancers, a new report found. Pathologist Jinru Shia was quoted.

February 15, 2012
Livingston Cancer Victim Lives On through Cycling Fundraiser

Memorial Sloan Kettering patient Jennifer Goodman Linn co-founded Cycle for Survival, an indoor cycling event that started as a single-gym fundraiser with a five-figure goal but has now raised more than $14 million for cancer research. Her oncologist, Gary Schwartz, was quoted.

February 10, 2012
Girl Riddled with Cancer Tumors Now in Remission after Pioneering Treatment in US

8H9, a promising new treatment that targets neuroblastoma cells, is helping two-year-old Lilly MacGlashan beat cancer. Lilly’s pediatric oncologist, Kim Kramer, said, “We have made great progress and have treated plenty of children who have beaten this and gone on to live good lives without the cancer coming back anywhere in their bodies.”

February 7, 2012
Daughter Diagnosed with Leukemia Inspires Father to Ride

Christopher Sarro, whose daughter was diagnosed with leukemia last year, is participating in this year’s Cycle for Survival to raise funds for cancer research at Memorial Sloan Kettering. The indoor cycling event, co-founded in 2007 by Jennifer Goodman Linn, who lost her battle with cancer last year, is Memorial Sloan Kettering’s most successful patient-run fundraiser to date. Ms. Linn’s oncologist, Gary Schwartz, was quoted.

February 6, 2012
Experimental Drug Shows Promising Results for Men with Prostate Cancer

Memorial Sloan Kettering patient John O’Mara and his oncologist, Daniel Danila, spoke about the investigational oral drug MDV3100, which is improving outcomes in patients with advanced prostate cancer. Mr. O’Mara, a clinical trial subject who is receiving the drug, said, “I do look at the future, even though I’m quite an old man, with a great deal more confidence.”

February 6, 2012
Gaining on Prostate Cancer

The investigational oral drug MDV3100 significantly improved overall survival in patients with advanced prostate cancer, according to results presented by lead investigator Howard Scher at a recent medical meeting. Lab work conducted by Charles Sawyers and colleagues was instrumental in the development of this novel therapy.

January 31, 2012
Breast Cancer Surgery Rules Are Called Unclear

Breast Surgical Chief Monica Morrow said that a new study might help push professional groups to develop guidelines for lumpectomy surgery, the most common operation to treat breast cancer. According to the study, nearly half of women who had lumpectomies for breast cancer had second operations they may not have needed.

January 31, 2012
Catch Me If You Can

Infectious disease specialist Kent Sepkowitz authored this opinion on cancer screening tests. Enthusiasm for routine mammography and PSA screening has waned recently, as the US Preventive Services Task Force has changed its recommendations for such screening measures. “Perhaps what is lacking,” Dr. Sepkowitz said, “is a respect for the calm pace required for true innovation.”

January 30, 2012
Pricey Surgery Robots Lack Clear Benefits

Gynecologic oncologist Mario Leitao argued that doctors shouldn’t give up on robots despite a new study that found similar complication rates among women treated for endometrial cancer with robotic surgery versus traditional laparoscopy.

January 30, 2012
Cycle Event Raises Funds, Honors Cancer Patient

Memorial Sloan Kettering patient Jennifer Goodman Linn co-founded Cycle for Survival, an annual cycling event to raise awareness for rare cancers. Katie Kotkins, who heads the initiative, said that more than $12 million has been raised since the organization’s inception.

January 25, 2012
Americans: Nursing Most Honest, Ethical Profession

When asked which profession they think is the most honest and ethical, Americans rank nursing No. 1. Nurses consistently have topped Gallup’s annual poll since the profession was first included in 1999. Ann Culkin, a nurse on the Thoracic Oncology Service, weighed in on why she believes nursing is so trusted by Americans.

January 23, 2012
Adolescents More Likely to Ignore Sun Protection As They Age

Epidemiologist Stephen Dusza led a study that found that most children do not regularly use sunscreen. Dr. Dusza and his team of investigators surveyed 360 fifth graders over three years and found that half of the children who routinely used sunscreen at the beginning of the study no longer did so three years later.

January 23, 2012
US Indoor Tanning Tax Having Mixed Effects

A new survey found that only a handful of indoor tanning salons reported a drop in clients after a 2010 federal excise tax was implemented to deter customers from using indoor tanning services. Steven Wang, head of dermatology in Basking Ridge, was quoted.

January 19, 2012
Cancer-Fighting Food Tactics

Registered dietitian Margaret Ziegler offered tips and nutrition information for people living with cancer. She said that there is no “one-size-fits-all” approach because the experience of cancer is so individualized and every person with cancer has a unique experience.

January 16, 2012
Cancer Barbie: Backers Seeking Bald Doll to Help Sick Kids Come to Terms with Hair Loss

Two women whose lives have been touched by cancer started an online campaign urging toy manufacturer Mattel to produce a bald Barbie doll to help kids cope with hair loss. Child psychiatrist and pediatrician Abraham Bartell was quoted.

January 12, 2012
New Prostate Cancer Gene Mutation Discovered

Surgery Chair Peter Scardino commented on the discovery of a new gene mutation linked to a higher risk of developing hereditary prostate cancer. Dr. Scardino said that with further research, the new gene mutation might be one of many in a panel that clinicians could screen for in order to determine which men should receive prostate cancer testing at a younger age.

January 11, 2012
Cycling for Rare Cancers

Dave Linn, co-founder of Cycle for Survival, talked about his wife, Memorial Sloan Kettering patient Jennifer Goodman Linn, whose tireless efforts to raise awareness for rare cancers led to the establishment of one of the world’s fastest-growing athletic fundraising events. Cycle for Survival has raised more than $12 million in support of lifesaving research on rare cancers at Memorial Sloan Kettering.

January 5, 2012


Memorial Sloan Kettering’s Paul Chapman, MD, Selected for the “Best of 2011” List

Esquire Magazine named Memorial Sloan Kettering’s Paul Chapman as one of the 77 reasons to celebrate in 2011 for his work with the drug vemurafenib. In clinical trials for treating melanoma, the drug proved so successful that the trial was halted early, so all patients could benefit from the therapy.

December 28, 2011
Avastin Passes Test in Delaying Ovarian Cancer

Memorial-Sloan Kettering’s Carol Aghajanian discussed a study that showed that for women with advanced cases of ovarian cancer, the drug Avastin adds about four months to the time it takes for the cancer to worsen.

December 28, 2011